Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Lenalidomide Dosing and Outcomes in...
Conference

Lenalidomide Dosing and Outcomes in Transplant-Ineligible Patients with Newly-Diagnosed Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database

Abstract

Abstract Introduction

Authors

Mian HS; Leblanc R; Louzada ML; Masih-Khan E; McCurdy A; Venner CP; Stakiw J; Kardjadj M; Jimenez-Zepeda VH; Sebag M

Volume

138

Publisher

American Society of Hematology

Publication Date

November 5, 2021

DOI

10.1182/blood-2021-148191

Conference proceedings

Blood

Issue

Supplement 1

ISSN

0006-4971